Published 2020 | Version v1

Publication Metadata-only

Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS

Creators: Novi G.; Ivaldi F.; Sbragia E.; Mikulska M.; Pesce G.; Inglese M.; Kerlero de Rosbo N.; Uccelli A.

Others:: Novi, G.; Ivaldi, F.; Sbragia, E.; Mikulska, M.; Pesce, G.; Inglese, M.; Kerlero de Rosbo, N.; Uccelli, A.

Additional details

Created:: April 14, 2023
Modified:: November 30, 2023